These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1390 related items for PubMed ID: 24439393

  • 1. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
    Ziakas PD, Kourbeti IS, Mylonakis E.
    Clin Ther; 2014 Feb 01; 36(2):292-306.e1. PubMed ID: 24439393
    [Abstract] [Full Text] [Related]

  • 2. Newer antifungal agents for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
    Xu SX, Shen JL, Tang XF, Feng B.
    Transplant Proc; 2013 Feb 01; 45(1):407-14. PubMed ID: 23375330
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Sohn HS, Lee TJ, Kim J, Kim D.
    Clin Ther; 2009 May 01; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
    [Abstract] [Full Text] [Related]

  • 4. Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
    Xu SX, Shen JL, Tang XF, Feng B, Xu HQ.
    Eur Rev Med Pharmacol Sci; 2016 May 01; 20(2):381-90. PubMed ID: 26875911
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.
    Huang X, Chen H, Han M, Zou P, Wu D, Lai Y, Huang H, Chen X, Liu T, Zhu H, Wang J, Hu J.
    Biol Blood Marrow Transplant; 2012 Oct 01; 18(10):1509-16. PubMed ID: 22469884
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials.
    Chen Q, Lin MH, Chen ML, Liu ZY, Chai D, Wang R.
    Chin Med J (Engl); 2012 Jan 01; 125(2):345-51. PubMed ID: 22340571
    [Abstract] [Full Text] [Related]

  • 10. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.
    Vardakas KZ, Michalopoulos A, Falagas ME.
    Br J Haematol; 2005 Oct 01; 131(1):22-8. PubMed ID: 16173959
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.
    Bone Marrow Transplant; 2006 Jul 01; 38(2):127-34. PubMed ID: 16751782
    [Abstract] [Full Text] [Related]

  • 13. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Wang CH, Kan LP, Lin HA, Chang FY, Wang NC, Lin TY, Chao TY, Kao WY, Ho CL, Chen YC, Dai MS, Chang PY, Wu YY, Lin JC.
    J Microbiol Immunol Infect; 2016 Aug 01; 49(4):531-8. PubMed ID: 25440977
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS, Fung HB.
    Clin Ther; 2007 Sep 01; 29(9):1862-86. PubMed ID: 18035188
    [Abstract] [Full Text] [Related]

  • 16. Antifungal prophylaxis in hematopoietic stem cell transplant recipients.
    Marr KA.
    Oncology (Williston Park); 2001 Nov 01; 15(11 Suppl 9):15-9. PubMed ID: 11757846
    [Abstract] [Full Text] [Related]

  • 17. Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.
    Bow EJ, Vanness DJ, Slavin M, Cordonnier C, Cornely OA, Marks DI, Pagliuca A, Solano C, Cragin L, Shaul AJ, Sorensen S, Chambers R, Kantecki M, Weinstein D, Schlamm H.
    BMC Infect Dis; 2015 Mar 17; 15():128. PubMed ID: 25887385
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.